Forget Lilly and Novo: Pfizer Is Planning a Wave of Phase 3 Obesity Trials

The Motley Fool · Reuben Gregg Brewer · 2026-11-07 21:15 UTC

Everyone is talking about the GLP-1 battle between Eli Lilly and Novo Nordisk, but Pfizer wants in on the fight, too.

Read the full story at The Motley Fool · All coverage of this story